‘Climate action is critical, but ESG investors must also keep up the fight against antibiotic resistance’
Author: Maria Lettini
Last week was significant for me, not only because it was my birthday, but because I joined FAIRR’s Founder Jeremy Coller at the World Economic Forum in Davos to launch the Investor Year of Action on AMR (antimicrobial resistance) alongside two of our partners Professor Dame Sally Davies, UK Special Envoy on AMR, and the UK Secretary of State for Health and Social Care, Matt Hancock. Needless to say, it was far from an ordinary birthday celebration.Image: Channels: Business StrategyTags: WEFDavosfactory farmingFAOInvestor Year of Action on AMRfast-food industry
This story was originally published by Ethical Corporation and can be accessed here.